Search the Newsreel

Independent Bank Corp. (INDB) Stock Forecasts

Argus has lowered its target price for Independent Bank Corp. (INDB) to $93.00, citing its role as a bank holding company for Rockland Trust Company. The report, dated August 12, 2026, also mentions similar target price reductions for other financial institutions. Investors can access …

Do Extendicare’s (TSX:EXE) Steady Dividend and Mixed Profits Reveal Its True Capital Priorities?

Wendy's (WEN) Faces Take Private Bid As Consortium Offer Nears

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Wendy's (NasdaqGS: WEN) is reportedly the focus of an advanced take-private bid led by its largest shareholder, Trian Fund Management. Trian is said to be …

Nuveen Churchill Direct Lending Earnings Call Shows Resilience

Nuveen Churchill Direct Lending (NCDL) reported Q2 net investment income of $0.41 per share, covering its $0.36 distribution, despite a 1.8% decline in net asset value to $17.19 per share due to credit challenges. The company declared a total Q3 distribution of $0.38 per …

Carlyle Secured Lending Inc. Q2 2026 Earnings: Modest EPS Beat Delivered as Shares Slip 0.63% - Estimate Dispersion

Blackstone Secured Lending Fund Revises Senior Secured Credit Agreement with Key Extensions and Adjustments

Blackstone Secured Lending Fund (NYSE:BXSL) announced a fifth amendment to its senior secured credit agreement, extending key borrowing and maturity dates while adjusting commitment amounts. The amendment prolongs the borrowing period for certain revolving commitments to August 10, 2030, and the maturity date to …

Ascendis Pharma (ASND) issues 15,060 staff warrants at $254.57 strike price

Ascendis Pharma A/S has granted 15,060 warrants to employees, with an exercise price of US $254.57 per share, matching the closing price on the grant date of August 11, 2026. These warrants vest over time, with 25% vesting after one year and the remainder …

Shoplifting survey points to financial strain as Americans struggle with costs

A new LendingTree survey reveals that 30% of American adults admit to shoplifting, an increase from 23% in 2024, with food and drinks being the most commonly stolen items. This rise is attributed to financial strain as Americans struggle with high costs, leading some …

Wendy's Shares Rise As Nelson Peltz's Trian Prepares Takeover Bid

(RTTNews) - Shares of The Wendy's Company (WEN) jumped as much as 15 percent on Wednesday after reports that Nelson Peltz's Trian Fund Management is preparing a proposal to take the struggling burger chain private. Trading in the stock was temporarily halted due to …

Wendy's Shares Jump As Nelson Peltz's Trian Prepares Takeover Bid

(RTTNews) - Shares of The Wendy's Company (WEN) jumped as much as 15 percent on Wednesday after reports that Nelson Peltz's Trian Fund Management is preparing a proposal to take the struggling burger chain private. Trading in the stock was temporarily halted due to …

Blackstone Secured Lending Fund (BXSL) extends revolver maturities, resets covenants in $2.375B facility

Blackstone Secured Lending Fund (BXSL) has amended its senior secured credit agreement, extending the maturity of most revolving commitments from August 2030 to August 2031, and the borrowing period for certain revolving commitments to August 2030. The aggregate commitments have been adjusted from $2.425 …

Vendome Acquisition Q2 FY26 net income rises to $1.59 million

Vendome Acquisition reported a net income of $1.59 million for Q2 FY26, primarily due to $1.78 million in trust investment income. Operating expenses totaled $196,740, partially offset by interest gains. The company's Trust Account held $207.38 million in investments as of June 30, 2026.

Vendome Acquisition (VNME) earns $3.2M on trust interest, holds $207M for deal

EURO-TREND-YAT-ORT, ETYAT Bilanço

Wendy's stock surges on potential takeover bid: AlphaSpace breakdown

Wendy's (WEN) stock is surging on reports of a pending takeover bid to take the company private. Yahoo Finance Senior Reporter Brooke DiPalma outlines the details. Yahoo Finance's AlphaSpace is a premium investment platform that combines data, charting, news, analysis, and more to help …

Legend Biotech Shares Fall After Oppenheimer Downgrade

Legend Biotech's shares experienced a decline following an Oppenheimer downgrade from Outperform to Perform, citing potential pressures from competition and a CEO transition. Despite this, RBC maintained an Outperform rating for Legend Biotech, adjusting its price target slightly, due to positive outlooks on Carvykti …

Wendy’s Stock Soars on Report Trian Partners Prepares Bid to Take Company Private

Wendy’s tells Barron’s it would ‘thoroughly review any proposal submitted by Trian consistent with its fiduciary duties.’ Continue Reading

Blend Labs at canaccord growth conference: ai underwriting gains traction

Nelson Peltz's Trian preparing take-private bid for Wendy's

According to a source familiar with the matter, Trian Fund Management — the firm led by Nelson Peltz — is putting together a group of investors with the goal of taking Wendy's private, Reuters reported Wednesday. Wendy's stock jumped as much as 15% on …

BXSL to MXN: Blackstone Secured Lending Fund (Dinari Tokenized Stock) Price in Mexican Peso

This article provides the current conversion rate of Blackstone Secured Lending Fund (Dinari Tokenized Stock) (BXSL) to Mexican Peso (MXN), stating that 1 BXSL is worth MX$410.86. It outlines steps on how to buy BXSL using MXN on both centralized and decentralized exchanges. The …

Prime Dividend Corp Stock Surges 7.37% as Trading Activity Spikes and Market Attention Builds

Legend Biotech (NASDAQ:LEGN) Trading Down 5.3% Following Analyst Downgrade

LEGN Downgraded by Oppenheimer -- Price Target Lowered to $40.00

Why Endeavour Silver (TSX:EDR) Is Up 25.6% After Securing New Credit Line And Returning To Profit

Legend Biotech stock downgraded at Oppenheimer (LEGN:NASDAQ)

Oppenheimer downgraded Legend Biotech (LEGN) to Perform from Outperform following the resignation of its CEO, competitive pressures, and reduced M&A prospects. The analyst cited these factors as reasons for the downgrade. Legend Biotech's shares saw a decline on Wednesday after the announcement.

Mendelson Infrastructures & Industries Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Opendoor Stock Plunges 20% in a Month: Should You Buy at Low or Wait?

Opendoor Technologies Inc. (OPEN) has experienced a 20.2% stock plunge in the last month, attributed to a challenging housing market with high mortgage rates and inflationary pressures. Despite near-term profitability struggles due to its capital-intensive model, the company is pursuing acquisitions, cost reductions, and …

Oppenheimer downgrades Legend Biotech stock rating on M&A concerns

Oppenheimer downgraded Legend Biotech (NASDAQ:LEGN) to Perform from Outperform, lowering its price target to $40 due to diminished M&A prospects, particularly after Johnson & Johnson was removed as a potential buyer. The firm also cited concerns over the CEO's departure, financing issues, and weak …

JHS Svendgaard Retail Ventures accepts Dr. Deepali Bhardwaj resignation

Newtrend Group Sets August Board Meeting to Review Interim Results and Dividend

We Think Crexendo's (NASDAQ:CXDO) Profit Is Only A Baseline For What They Can Achieve

Crexendo's recent earnings report, while seemingly underwhelming to some investors, suggests a stronger underlying financial position than initial perceptions. The company's negative accrual ratio indicates that its statutory earnings are significantly less than its free cash flow, and unusual items further contribute to a …

RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating

RBC Capital Markets has adjusted its price target for Legend Biotech (LEGN) to $58, down from $59, while reiterating an Outperform rating on the stock. This revision comes amidst recent news for Legend Biotech, including a downgrade from Oppenheimer and the company reporting its …

The Top 5 Analyst Questions From Oaktree Specialty Lending’s Q2 Earnings Call

Extendicare Inc. Stock Faces Renewed Pressure as Investor Caution Builds

Legend Biotech Releases Q2 2026 Financial Results

Legend Biotech (LEGN) reported strong Q2 2026 financial results, with adjusted earnings of $0.16 per share, surpassing estimates. The company generated $387.5 million in revenue, largely driven by its CARVYKTI collaboration, indicating significant growth and market penetration for its cell therapy platform. Wall Street …

Legend Turns Profitable In Q2 As CARVYKTI Sales Jump By 50%

(RTTNews) - Legend Biotech Corporation (LEGN) released financial results for the second quarter ended June 30, 2026. The commercial-stage company turned profitable in the second quarter, compared with a loss in the prior-year quarter, driven by higher collaboration revenue and improved operating income. For …